On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
One of the biggest Medicare Advantage fraud cases has hit a snag, with government officials saying they don’t have access to ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
A preclinical next-gen obesity drug is stacking five mechanisms (in mice). Also, the NIH funding climate is rougher than ever ...
FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K ...
The runup to next month’s annual meeting of the American Society of Clinical Oncology has started, and a good bit of the Wall ...
New FDA contamination testing results on 312 samples from 16 brands confirm the safety of infant formula in the U.S., the ...
A new social media narrative claims international grads are stealing American doctors’ jobs. These authors did the math to ...
A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results